Effect of μ, δ and κ Opioid Receptor Agonists on a Reactive Oxygen Species Mediated Model of Skin Inflammation

Skin Pharmacology and Physiology

Volumn 9, Issue 4, 1996, Pages 250-258

  Earl, J R ^a   Grootveld, M C ^a   Blake, D R ^a   Morris, C J ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

DAMGO; DPDPE; Opioid agonists; Reactive oxygen species; Skin inflammation; U50488

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; DELTA OPIATE RECEPTOR; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; GLUCONIC ACID; GLUCOSE OXIDASE; HYDROGEN PEROXIDE; KAPPA OPIATE RECEPTOR; MU OPIATE RECEPTOR; NALTREXONE; OPIATE AGONIST; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN INFLAMMATION;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANALGESICS; ANIMALS; DERMATITIS; ENKEPHALIN, D-PENICILLAMINE (2,5)-; ENKEPHALINS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PYRROLIDINES; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; RECEPTORS, OPIOID; SKIN;

EID: 0029736911     PISSN: 16605527     EISSN: 16605535     Source Type: Journal    
DOI: 10.1159/000211422     Document Type: Article

References (36)

1. Merry P, Winyard PG, Morris CJ, Grootveld MC, Blake DR: Oxygen free radicals, inflammation, and synovitis: The current status. Ann Rheum Dis 1989:48:864-870.
2. Schopf RE, Allmeyer P, Lemmel EM: Increased respiratory burst activity in monocytes and polymorphonuclear leukocytes in psoriasis. Br J Dermatol 1982;107:505-510.
3. Miyachi Y, Uchida K, Komura J, Asada Y, Niwa Y: Auto-oxidative damage in cement dermatitis. Arch Dermatol Res 1985:277:288-292.
4. Sharkey P, Eedy DJ, Burrows D, McCaigue MD, Bell AL: A possible role for superoxide production in the pathogenesis of contact dermatitis. Acta Derm Venereol (Stockh) 1991:76:156-159.
5. Edmonds SE, Blake DR, Morris CJ, Winyard PG: An imaginative approach to synovitis - the role of hypoxic rcperfusion damage in arthritis. J Rheumatol 1993;20:26-31.
6. McCord JM: Oxygen-derived free radicals in post-ischaemic tissue injury. N Engl J Med 1985:312:159-163.
7. Boyd AG, Sherman IA, Saibil FG, Mamelak M: The protective effect of y-hydroxybutvrate in regional intestinal ischaemia in the hamster. Gastroenterology 1990:99:860-862.
8. Pleuvry BJ: Opioid receptors and awareness of the grcek alphabet. Br J Hosp Med 1992:48:678-681.
9. Tercnius L: Opiate receptors - the historical breakthrough in drug research. Bichem Soc Symp 1993:59: 13-25.
10. Birch PJ, Rogers H, Hayes AG, Hayward NJ, Tyers MB, Scopes DIC, Naylor A, Judd DB: Ncuro-protective actions of GR89696. a highly potent and selective x-opioid receptor agonist. Br J Pharmacol 1991:103:1819-1823.
11. Hayward NJ, McKnight AT, Woodruff GN: Neuroprotectivc effect of the x-agonisl Enadoline (C1-977) in rat models of focal cerebral ischaemia. Eur J Neurosci 1993:5:961 -967.
12. Iversen LL: Pharmacological approaches to the treatment of ischaemic neuronal damage. Eye 1991: 5:193-197.
13. Silvia RC, Slizgi GR, Ludens JH, Tang AH: Protection from ischemia-induced cerebral edema in the rat by U50488H, a kappa opioid receptor agonist. Brain Res 1987; 403:52-57.
14. Tang AH: Protection from cerebral ischemia by U50488. a specific kappa opioid agonist. Life Sci 1985;37: 1475-1482.
15. Hargreaves KM, Dubner R, Joris J: Peripheral actions of opiates in the blockade of carrageenan-induced inflammation. Proceedings of the Vth World Congress on Pain. Amsterdam, Elsevier. 1988. pp 55-60.
16. Joris J, Costello A, Dubner R, Hargreaves KMP: Opiates suppress car-ragcenan-induced edema and hypothermia at doses that inhibit hyperalgesia. Pain 1990:43:95-103.
17. Russel NJW, Jamieson A, Callen TS, Ranee MJ: Peripheral opioid effects upon neurogenic plasma extravasation and inflammation. Br J Pharmacol 1985:86:788P.
18. Hadkipetrou-Kourounaki L, Rekka E, Kourounakis A: Suppression of adjuvant-induced disease (AID) by a novel analgesic-opioid agonist which also possesses antioxidant activity. Ann NY Acad Sci 1992:650: 19-24.
19. Ando Y, Inouc M, Araki S, Morino Y: Inhibition of carrageenan-in-duced paw oedema by a Superoxide dismutase derivative that circulates bound to albumin. Biochint Biophys Acta 1991;1073:374-379.
20. Dabbagh AJ, Blake DR, Morris CJ: Effect of iron complexes on adjuvant arthritis in rats. Ann Rheum Dis 1992;51:516-521.
21. Silbert BS, Lipkowski AW, Solcdad Cepeda M, Szyfelbein SK, Osgood PF, Carr DB: Enhanced potency of receptor-selective opioids after acute burn injury- Anesth Analg 1991;73:427-433.
22. Trenam CW, Dabbagh AJ, Blake DR, Morris CJ: Skin inflammation induced by reactive oxygen species (ROS): An in-vivo model. Br J Dermatol 1991;125:325-329.
23. Contreras PC, Ragan DM, Bremer ME, Lanthom TH, Gray NM, Iyengar S, Jacobson AE, Rice KC. de Costa BR: Evaluation of U-50.488H analogs for neuroprotectivc activity in the gerbil. Brain Res 1991:546: 79-82.
24. Buckingham JC, Cooper TA: Differences in hypothalamo-pituitary-adrenocortical activity in the rat after acute and prolonged treatment with morphine. Neuroendocrinology 1984;38:411-417.
25. Eisenberg RM: DAMGO stimulates the hypothalamo-piluitary-adrenal axis through a mu-2 opioid receptor. J Pharmacol Exp Ther 1993:266: 985-991.
26. Alcaraz C, Milanis MV, Vargas ML: Chronic kappa opioid receptor antagonism produces supersensitivity to U-50488H at the hypothalamus-pituitary-adrcnocortical (HPA) axis level. J Pharmacol Exp Ther 1993; 266:1385-1389.
27. Gonzalvez ML, Milanes MV, Vargas ML: Effects of acute and chronic administration of mu- and delta-opioid agonists on the hypothalamic-pituitary-adrenocortical (HPA) axis in the rat. Eur J Pharmacol 1991:23:200:155-158.
28. Green PG, Levine JD: 8 and k opioid agonists inhibit plasma extravasation induced by bradykinin in the knee joint of the rat. Neuroscience 1992:49:129-133.
29. Slefano GB: Role of opioid neuropeptides in immunorcgulation. Prog Neurobiol 1989:33:149-159.
30. Carr DJJ: The role of opioids and their receptors in the immune system. Proc Soc Exp Biol Med 1991: 198:710-720.
31. Taub DD, Eisenstein TB, Geller EB, Adler MW, Rogers TJ: Immunomodulatory activity of g- and x-selectivc opioid agonists. Proc Natl Acad Sci USA 1991:88:360-364.
32. Przewlocki R, Hassan AHS, Lason W, Epplen C, Herz A, Stein C: Gene expression and localization of opioid peptides in immune cells of inflamed tissue: Functional role in antinociception. Neuroscience 1992; 48:491-500.
33. Veljic J, Ranin J, Marie D, Jankovic BD: Modulation of cutaneous immune reactions by centrally applied mcthioninc-enkephalin. Ann NY Acad Sci 1992;650:51-55.
34. Peterson PK, Sharp B, Gekker G, Brummitt C, Keane WF: Opioid-mediated suppression of cultured peripheral blood mononuclear cell respiratory burst activity. J Immunol 1987;138:3907-3912.
35. Fuchs J, Milbradt R: Antioxidant inhibition of skin inflammation induced by reactive oxygen species: Evaluation of the redox couple dihy-drolipoate/iipoatc. Skin Pharmacol 1994:7:278-284.
36. Taiwo YO, Levine JD: k- and 8-opioids block sympathetically dependent hyperalgesia. J Neurosci 1991;11:928-932.